Senestech (NASDAQ:SNES) Trading Up 1.4% – What’s Next?

Senestech, Inc. (NASDAQ:SNES)’s share price rose 1.4% on Thursday . The company traded as high as $1.54 and last traded at $1.40. 89,042 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 58,374 shares. The stock had previously closed at $1.38.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of Senestech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Senestech currently has an average rating of “Hold”.

Senestech Stock Up 1.4%

The company has a market cap of $7.42 million, a P/E ratio of -0.74 and a beta of 0.28. The company has a debt-to-equity ratio of 0.02, a current ratio of 8.91 and a quick ratio of 7.79. The stock has a fifty day moving average price of $1.58 and a two-hundred day moving average price of $1.77.

Senestech (NASDAQ:SNES) last released its quarterly earnings results on Tuesday, May 12th. The company reported ($0.31) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.02. Senestech had a negative return on equity of 67.60% and a negative net margin of 304.22%.The business had revenue of $0.49 million during the quarter, compared to analyst estimates of $0.63 million. On average, research analysts expect that Senestech, Inc. will post -1.57 EPS for the current year.

Insider Activity at Senestech

In other news, major shareholder Glenbrook Capital Management purchased 35,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 30th. The shares were bought at an average cost of $1.51 per share, with a total value of $52,850.00. Following the completion of the transaction, the insider directly owned 1,022,824 shares of the company’s stock, valued at approximately $1,544,464.24. This trade represents a 3.54% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders have bought a total of 111,773 shares of company stock valued at $177,762 in the last three months. Corporate insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Senestech

A number of institutional investors have recently added to or reduced their stakes in the company. Sabby Management LLC lifted its position in shares of Senestech by 195.4% during the 4th quarter. Sabby Management LLC now owns 210,564 shares of the company’s stock worth $451,000 after buying an additional 139,281 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Senestech by 35.2% during the fourth quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock valued at $306,000 after acquiring an additional 37,165 shares during the last quarter. DRW Securities LLC lifted its holdings in Senestech by 171.1% during the fourth quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock worth $176,000 after acquiring an additional 51,818 shares during the period. Jane Street Group LLC bought a new stake in Senestech during the second quarter worth $161,000. Finally, Millennium Management LLC purchased a new position in Senestech in the third quarter worth $126,000. 5.19% of the stock is owned by institutional investors.

Senestech Company Profile

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.